Smith & Nephew PLC
Fechado
1,049 4.17
Visão Geral
Variação de preço das ações
24h
Mín
1007
Máximo
1014.5
Rendimento | -42M 301M |
|---|---|
Vendas | -234M 3.1B |
P/E Médio do Setor | 19.824 32.138 |
Rendimento de Dividendos | 3.73 |
Margem de lucro | 9.784 |
Funcionários | 17,000 |
EBITDA | -113M 773M |
Rendimento de Dividendos Médio do Setor | 3.73% 3.59% |
|---|---|
Próxima data de dividendos | 6 de nov. de 2026 |
Próxima data de ex-dividendo | 1 de out. de 2026 |
Capitalização de Mercado | -390M 9B |
|---|---|
Abertura anterior | 1044.83 |
Fecho anterior | 1049 |
Smith & Nephew PLC Gráfico
O desempenho passado não é um indicador confiável de resultados futuros.
Notícias Relacionadas
Comparação entre Pares
Variação de preço
Smith & Nephew PLC Previsão
Informação Financeira
Custos administrativos e de venda
Custos Operacionais
Lucro antes de imposto
Vendas
Custo das vendas
Lucro bruto sobre vendas
Despesa com juros da dívida
EBITDA
Resultado Operacional
$
Sobre Smith & Nephew PLC
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
